Moffitt at ASH

Researchers in the Moffitt lab

The 63rd installment of the American Society of Hematology (ASH) Annual Meeting was held at the Georgia World Congress Center in Atlanta, Georgia – and virtually – from December 11-14, 2021.

This year, Moffitt authors were listed on 143 abstracts that showcased the latest advances in hematology. In total, there were 52 oral and poster presentations presented by Moffitt authors, three scientific symposia featuring Moffitt speakers; and one education session with a Moffitt speaker.

Moffitt at ASH Virtual Program

 

Featured Articles

patient receiving an infusion

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner
Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care.

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?
Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies.

Do Racial and Ethnic Differences Impact Outcomes in Multiple Myeloma?
“A lot of the genetic and molecular differences we found have direct therapeutic implications,” Moffitt study shows.

UltraCAR-T™ Shows Promise for Treating Myeloid Malignancies
Fast-acting treatment aims to extend lives when minutes matter.

Media Contact:

For additional information on Moffitt’s research presented at ASH please reach out to:

Photo of Kim Polacek
Kim Polacek, APR, CPRC
Senior PR Account Coordinator
Email


Videos


See a complete list of Moffitt ASH 2021 videos in our playlist.

 

Moffitt Resources

cells

Meet the Malignant Hematology Team

Our malignant hematology specialists have a unique level of experience treating patients.

BMT specialists

Meet the BMT & Cellular Immunotherapy Team

Due to the specialization of our team, we are able to achieve exceptional outcomes for our patients.

A group of African American at a meeting

Diversity, Equity and Inclusion

The diversity of our employees and communities is valued and supported as essential components to contributing to the prevention and cure of cancer.

Cancer Cells

Clinical Trials

With our robust portfolio of clinical trials, Moffitt remains firmly established at the forefront of cancer research.

Cell Therapies Lab

Cell Therapies Core

The Cell Therapies Core provides service to members to facilitate translation of promising therapies for cancer patients.

Physician liaison meeting with doctors

Physician Liaison Team

Our goal is to forge partnerships with healthcare professionals to improve patient access and outcomes.